Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

1754studies shown

Showing 1,633-1,644 of 1,754

Drug study icon

RecruitingNCT07046819

Tirzepatide in MetALD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 100 Years

Countries: United States
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition: Addiction

Behavioral study icon

RecruitingNCT07559500

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 21 Years to 65 Years

Countries: United States
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition: Addiction

Behavioral study icon

RecruitingNCT05931913

TMS + Exposure Therapy for Pediatric OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDBehavioralFrom 12 Years to 21 Years

Countries: United States
Sponsor: Bradley Hospital
Condition: OCD

Behavioral study icon

RecruitingNCT06155682

TMS for Inhibition Enhancement in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralFrom 18 Years to 45 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

Device study icon

RecruitingNCT07401225

TMS for PTSD in Youth

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDeviceFrom 12 Years to 20 Years

Countries: United States
Sponsor: The University of Texas Health Science Center at San Antonio
Condition: PTSD

Behavioral study icon

RecruitingNCT07171359

TMS to Improve Recovery Outcomes Among people with Addiction (OUD) and Addiction (AUD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: Washington State University
Condition: Addiction

Behavioral study icon

RecruitingNCT05405803

To Improve Depressive Symptoms Using a Web-App

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

DepressionBehavioralFrom 40 Years to 60 Years

Countries: United States
Sponsor: University of Texas at Austin
Condition: Depression

Drug study icon

RecruitingNCT05770375

Tolerability of MDMA in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Anya Bershad, MD, PhD
Condition: Schizophrenia

Drug study icon

RecruitingNCT04366518

Toward a Computationally-Informed, Personalized Treatment for Hallucinations

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Behavioral study icon

RecruitingNCT07010978

Towards Testing the Effectiveness of Recovery Community Centers (RCCs)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Addiction

Behavioral study icon

RecruitingNCT05576350

TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 35 Years

Countries: United States
Sponsor: University of Kentucky
Condition: Addiction

Device study icon

RecruitingNCT03952962

Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDeviceFrom 21 Years to 70 Years

Countries: United States
Sponsor: Nader Pouratian
Condition: Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.